Drug Lowers Body’s ‘Set Point’ To Control Hyperparathyroidism In Dialysis Patients
A medication called cinacalcet an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD) works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN). Cinacalcet is one of a family of drugs called calcimimetics.
More: continued here
Filed under: Endocrinology on July 25th, 2008